Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial

• Main Authors: Yongliang Feng (Author), Xiaohong Shi (Author), Jing Shi (Author), Linying Gao (Author), Guangming Liu (Author), Yanpeng Cheng (Author), Minghu Pan (Author), Chunxia Li (Author), Jun Wang (Author), Xuxia Guo (Author), Yawei Zhang (Author), Xiaofeng Liang (Author), Suping Wang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: To evaluate the immunogenicity, antibody persistence, and safety of the 60 µg hepatitis B vaccine in hemodialysis patients in China. Methods: We conducted a multicenter, randomized, double-blind, parallel-controlled trial including 352 hemodialysis patients who were centrally randomized...